Literature DB >> 18023819

SVIR epidemic models with vaccination strategies.

Xianning Liu1, Yasuhiro Takeuchi, Shingo Iwami.   

Abstract

Vaccination is important for the elimination of infectious diseases. To finish a vaccination process, doses usually should be taken several times and there must be some fixed time intervals between two doses. The vaccinees (susceptible individuals who have started the vaccination process) are different from both susceptible and recovered individuals. Considering the time for them to obtain immunity and the possibility for them to be infected before this, two SVIR models are established to describe continuous vaccination strategy and pulse vaccination strategy (PVS), respectively. It is shown that both systems exhibit strict threshold dynamics which depend on the basic reproduction number. If this number is below unity, the disease can be eradicated. And if it is above unity, the disease is endemic in the sense of global asymptomatic stability of a positive equilibrium for continuous vaccination strategy and disease permanence for PVS. Mathematical results suggest that vaccination is helpful for disease control by decreasing the basic reproduction number. However, there is a necessary condition for successful elimination of disease. If the time for the vaccinees to obtain immunity or the possibility for them to be infected before this is neglected, this condition disappears and the disease can always be eradicated by some suitable vaccination strategies. This may lead to over-evaluating the effect of vaccination.

Entities:  

Mesh:

Year:  2007        PMID: 18023819     DOI: 10.1016/j.jtbi.2007.10.014

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  14 in total

1.  Dynamics analysis and optimal control of SIVR epidemic model with incomplete immunity.

Authors:  Yiming Liu; Shuang Jian; Jianguo Gao
Journal:  Adv Contin Discret Model       Date:  2022-07-18

2.  A time-delayed SVEIR model for imperfect vaccine with a generalized nonmonotone incidence and application to measles.

Authors:  Isam Al-Darabsah
Journal:  Appl Math Model       Date:  2020-10-01       Impact factor: 5.129

3.  Competitive analysis for stochastic influenza model with constant vaccination strategy.

Authors:  Dumitru Baleanu; Ali Raza; Muhammad Rafiq; Muhammad Shoaib Arif; Muhammad Asghar Ali
Journal:  IET Syst Biol       Date:  2019-12       Impact factor: 1.615

4.  A Diffusive Sveir Epidemic Model with Time Delay and General Incidence.

Authors:  Jinling Zhou; Xinsheng Ma; Yu Yang; Tonghua Zhang
Journal:  Acta Math Sci       Date:  2021-06-01       Impact factor: 1.258

5.  Vaccination Control in a Stochastic SVIR Epidemic Model.

Authors:  Peter J Witbooi; Grant E Muller; Garth J Van Schalkwyk
Journal:  Comput Math Methods Med       Date:  2015-05-24       Impact factor: 2.238

6.  Modelling infectious diseases with relapse: a case study of HSV-2.

Authors:  Jinliang Wang; Xiaoqing Yu; Heidi L Tessmer; Toshikazu Kuniya; Ryosuke Omori
Journal:  Theor Biol Med Model       Date:  2017-07-17       Impact factor: 2.432

7.  Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities.

Authors:  Andria Stylianou; Christoforos Hadjichrysanthou; James E Truscott; Roy M Anderson
Journal:  Parasit Vectors       Date:  2017-06-17       Impact factor: 3.876

8.  Vaccination strategies against COVID-19 and the diffusion of anti-vaccination views.

Authors:  Rafael Prieto Curiel; Humberto González Ramírez
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

9.  Vaccination control of an epidemic model with time delay and its application to COVID-19.

Authors:  Shidong Zhai; Guoqiang Luo; Tao Huang; Xin Wang; Junli Tao; Ping Zhou
Journal:  Nonlinear Dyn       Date:  2021-05-28       Impact factor: 5.741

10.  Beyond Rational Decision-Making: Modelling the Influence of Cognitive Biases on the Dynamics of Vaccination Coverage.

Authors:  Marina Voinson; Sylvain Billiard; Alexandra Alvergne
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.